Latest News

JoeysHindmarshGutsyThumb

Joeys show extra guts to fight cancer

Students of St. Joseph’s Catholic School in the Adelaide suburb of West Hindmarsh have shown their class – …

Click here to read more

DesmondYipThumb

Grasping the GIST of treating rare cancer

A new study into the rare and elusive Gastro-Intestinal Stromal Tumour (GIST) is opening to recruitment at ten …

Click here to read more

NickPavlakisThumb

Ambitious trial promises treatment progress

The AGITG has announced initial presentation of positive results of the multinational gastric cancer trial INTEGRATE, led by …

Click here to read more

RobRamsayThumb

New insight into bowel cancer origin

Researchers at Melbourne’s Peter MacCallum Cancer Centre have made important new findings about how bowel cancer starts, accelerates …

Click here to read more

GutsyTropfest2014thumb

Gutsy ad screened at Tropfest Canberra

The GI Cancer Institute has launched its new Community Service Announcement for the Gutsy Challenge The 15-second announcement …

Click here to read more

CAPmembersThumb

Consumer Advisory Panel: Call for Expressions of Interest

The Australasian Gastro‐Intestinal Trials Group (AGITG) is seeking expressions of interest from people affected by gastro‐intestinal cancer (survivors/patients/carers/family) …

Click here to read more

EngageSyd2014WebcastThumb

Webcast brings Engage forum to you

GI cancer researchers, clinicians, survivors and carers bring latest developments and insightful personal experiences into your home – …

Click here to read more

AmiteshRoyThumb

Anal cancer trial looks for answers

Donations to the GI Cancer Institute are funding AGITG participation in an international multi-centre study of best treatment …

Click here to read more

TimPriceThumb

New research grant – thanks to you!

The GI Cancer Institute has announced the launch of a new annual grant of up to $100,000 a …

Click here to read more

ACCNlaunchThumb

Consumer network welcomes inquiry

The Senate has announced a national inquiry into the availability of new, innovative and specialist cancer drugs in …

Click here to read more